Clinical Trial Update: Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma

View source ↗

Summary

Clinical trial update indicating a study evaluating volatile organic compound assessment in pancreatic ductal adenocarcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Imperial College London | Conditions: PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer | Status: RECRUITING